September 2019 FDA Recall Benazepril Hydrochloride by Amneal Pharmaceuticals, Inc.
D-0134-2020 - Presence of Foreign Tablet/Capsule; Promethazine HCl tablet found in the Benazepril HCl bottle

This Class III drug recall was voluntarily initiated by Amneal Pharmaceuticals, Inc. on September 24, 2019 for the product Benazepril Hydrochloride. The FDA reported the reason for recall as presence of foreign tablet/capsule; promethazine hcl tablet found in the benazepril hcl bottle. The product was distributed in Product was distributed to 13 major distributors throughout the United States who may have further distribute the product. and the recall is currently terminated.

Recall Number: D-0134-2020

Reason for Recall
Presence of Foreign Tablet/Capsule; Promethazine HCl tablet found in the Benazepril HCl bottle
Initiated
09-24-2019
Reported
10-16-2019
Quantity
9,720 100 count bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Amneal Pharmaceuticals, Inc.
Product was distributed to 13 major distributors throughout the United States who may have further distribute the product.
Benazepril HCl Tablets, USP 40 mg, 100 count bottles, Rx only, Distributed by Amneal Pharmaceuticals, Bridgewater, NJ NDC 65162-754-10

Batch or Lot Expiration Information

Lot# BB02619A, exp. date 04/2021